Status:
COMPLETED
BRCA Mutations in Latinas
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-99 years
Brief Summary
Background: \- BRCA1 and BRCA2 gene mutations have been linked to a higher risk of developing breast cancer and other cancers, and may be associated with types of breast cancer that are more difficul...
Detailed Description
BACKGROUND: * Mutations in the BRCA1 and BRCA2 genes predispose to breast and ovarian cancer, and are increasingly recognized in prostate and pancreatic cancers. * Basal/ Triple negative breast cance...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patient must be self-identified of Hispanic/Latino origin.
- Patients must have histologically or cytologically confirmed diagnosis of breast cancer.
- Age greater than or equal to 18 years.
- Ability to understand and the willingness to sign a written informed consent document.
- Must be willing and able to provide a saliva sample, answer questionnaire data online or complete a paper questionnaire, and request a copy of their pathology report.
- EXCLUSION CRITERIA:
- \- Males and subjects under the age of 18.
Exclusion
Key Trial Info
Start Date :
July 7 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT01251900
Start Date
July 7 2011
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest Cancer Center, Lubbock; Texas Tech University
Lubbock, Texas, United States, 79415